| 2016-12-01 17:06:46|
TARO 17:06 12/01 12/01/16
Taro Pharmaceutical names Abhay Gandhi interim CEO
Taro Pharmaceutical Industries announced that its board has appointed Abhay Gandhi to the position of interim CEO, effective January 1, 2017. As previously announced, the interim CEO will serve in this role during the period from Kal Sundaram's departure at the end of this year until the arrival in April 2017 of Uday Baldota, Taro's recently appointed CEO. Gandhi currently serves as the CEO of the Sun Pharmaceutical Industries North America operations, a position he succeeded from Sundaram. Taro's board has also nominated Mr. Gandhi to its board.